PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Instil Bio, Inc. (TIL)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US45783C1018

CUSIP

45783C101

Sector

Healthcare

IPO Date

Mar 19, 2021

Highlights

Market Cap

$141.55M

EPS (TTM)

-$11.56

Total Revenue (TTM)

$7.67M

Gross Profit (TTM)

$4.64M

EBITDA (TTM)

-$63.52M

Year Range

$6.72 - $92.00

Target Price

$100.33

Short %

10.03%

Short Ratio

2.29

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
TIL vs. PRCT TIL vs. SMMT
Popular comparisons:
TIL vs. PRCT TIL vs. SMMT

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Instil Bio, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%200.00%400.00%600.00%800.00%JulyAugustSeptemberOctoberNovemberDecember
102.56%
8.53%
TIL (Instil Bio, Inc.)
Benchmark (^GSPC)

Returns By Period

Instil Bio, Inc. had a return of 174.15% year-to-date (YTD) and 200.58% in the last 12 months.


TIL

YTD

174.15%

1M

-20.27%

6M

110.80%

1Y

200.58%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

24.34%

1M

0.23%

6M

8.53%

1Y

24.95%

5Y*

13.01%

10Y*

11.06%

Monthly Returns

The table below presents the monthly returns of TIL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202454.86%1.02%-9.40%0.19%-1.20%-3.74%18.37%14.53%382.58%-52.81%-15.30%174.15%
202329.19%-4.52%-14.97%-1.10%-8.20%-8.15%-0.91%-17.38%-5.12%-13.32%-8.68%12.46%-39.52%
2022-32.14%-7.58%0.19%-34.23%-15.06%-23.06%22.08%-7.80%-6.92%-31.82%-59.70%-52.63%-96.32%
2021-5.14%-18.14%-13.30%8.54%-22.10%25.25%-5.17%13.96%7.90%-22.16%-35.29%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 90, TIL is among the top 10% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of TIL is 9090
Overall Rank
The Sharpe Ratio Rank of TIL is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of TIL is 9595
Sortino Ratio Rank
The Omega Ratio Rank of TIL is 9393
Omega Ratio Rank
The Calmar Ratio Rank of TIL is 9191
Calmar Ratio Rank
The Martin Ratio Rank of TIL is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Instil Bio, Inc. (TIL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for TIL, currently valued at 1.40, compared to the broader market-4.00-2.000.002.001.402.10
The chart of Sortino ratio for TIL, currently valued at 3.45, compared to the broader market-4.00-2.000.002.004.003.452.80
The chart of Omega ratio for TIL, currently valued at 1.43, compared to the broader market0.501.001.502.001.431.39
The chart of Calmar ratio for TIL, currently valued at 2.03, compared to the broader market0.002.004.006.002.033.09
The chart of Martin ratio for TIL, currently valued at 6.20, compared to the broader market-5.000.005.0010.0015.0020.0025.006.2013.49
TIL
^GSPC

The current Instil Bio, Inc. Sharpe ratio is 1.40. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Instil Bio, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00JulyAugustSeptemberOctoberNovemberDecember
1.40
2.10
TIL (Instil Bio, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Instil Bio, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-96.14%
-2.62%
TIL (Instil Bio, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Instil Bio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Instil Bio, Inc. was 98.83%, occurring on Dec 7, 2023. The portfolio has not yet recovered.

The current Instil Bio, Inc. drawdown is 96.14%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.83%Mar 29, 2021680Dec 7, 2023
-9.59%Mar 23, 20213Mar 25, 20211Mar 26, 20214

Volatility

Volatility Chart

The current Instil Bio, Inc. volatility is 30.57%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%JulyAugustSeptemberOctoberNovemberDecember
30.57%
3.79%
TIL (Instil Bio, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Instil Bio, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Instil Bio, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab